Cargando…
Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3...
Autores principales: | Abuelizz, Hatem A., Iwana, Nor Azman N. I., Ahmad, Rohaya, Anouar, El-Hassane, Marzouk, Mohamed, Al-Salahi, Rashad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661812/ https://www.ncbi.nlm.nih.gov/pubmed/31384800 http://dx.doi.org/10.1186/s13065-019-0560-4 |
Ejemplares similares
-
Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study
por: Abuelizz, Hatem A., et al.
Publicado: (2019) -
Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives
por: Abuelizz, Hatem A., et al.
Publicado: (2017) -
Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies
por: Abuelizz, Hatem A., et al.
Publicado: (2020) -
Investigation the antioxidant activity of benzo[g]triazoloquinazolines correlated with a DFT study
por: Almehizia, Abdulrahman A., et al.
Publicado: (2019) -
Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives
por: Al-Salahi, Rashad, et al.
Publicado: (2016)